JP2014133703A - 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物 - Google Patents

生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物 Download PDF

Info

Publication number
JP2014133703A
JP2014133703A JP2011076643A JP2011076643A JP2014133703A JP 2014133703 A JP2014133703 A JP 2014133703A JP 2011076643 A JP2011076643 A JP 2011076643A JP 2011076643 A JP2011076643 A JP 2011076643A JP 2014133703 A JP2014133703 A JP 2014133703A
Authority
JP
Japan
Prior art keywords
family
cells
cell
subfamily
negative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011076643A
Other languages
English (en)
Japanese (ja)
Inventor
Mari Idesawa
真理 出澤
Masayori Yoshida
正順 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clio Inc
Original Assignee
Clio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clio Inc filed Critical Clio Inc
Priority to JP2011076643A priority Critical patent/JP2014133703A/ja
Priority to PCT/JP2012/059431 priority patent/WO2012133948A1/fr
Priority to US13/435,703 priority patent/US9399758B2/en
Priority to CN2012800165380A priority patent/CN103442724A/zh
Publication of JP2014133703A publication Critical patent/JP2014133703A/ja
Priority to US15/189,215 priority patent/US11261426B2/en
Priority to US16/104,224 priority patent/US20180355313A1/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2011076643A 2009-07-15 2011-03-30 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物 Withdrawn JP2014133703A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2011076643A JP2014133703A (ja) 2011-03-30 2011-03-30 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物
PCT/JP2012/059431 WO2012133948A1 (fr) 2011-03-30 2012-03-30 Composition pour thérapie cellulaire par allogreffe, ladite composition contenant une cellule souche pluripotente positive pour ssea-3 pouvant être isolée de tissu corporel
US13/435,703 US9399758B2 (en) 2009-07-15 2012-03-30 SSEA3(+) pluripotent stem cell that can be isolated from body tissue
CN2012800165380A CN103442724A (zh) 2011-03-30 2012-03-30 含有可从机体组织中分离的ssea-3阳性的多能干细胞的同种异体移植用细胞治疗用组合物
US15/189,215 US11261426B2 (en) 2009-07-15 2016-06-22 Pluripotent stem cell that can be isolated from body tissue
US16/104,224 US20180355313A1 (en) 2009-07-15 2018-08-17 Pluripotent stem cell that can be isolated from body tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011076643A JP2014133703A (ja) 2011-03-30 2011-03-30 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物

Publications (1)

Publication Number Publication Date
JP2014133703A true JP2014133703A (ja) 2014-07-24

Family

ID=46931620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011076643A Withdrawn JP2014133703A (ja) 2009-07-15 2011-03-30 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物

Country Status (3)

Country Link
JP (1) JP2014133703A (fr)
CN (1) CN103442724A (fr)
WO (1) WO2012133948A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017151060A (ja) * 2016-02-26 2017-08-31 国立大学法人岐阜大学 急性心筋梗塞の予後マーカー及びその利用
JP2020153991A (ja) * 2016-01-15 2020-09-24 国立大学法人富山大学 虚血性脳梗塞への多能性幹細胞の動員

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2790669T3 (es) * 2013-11-01 2020-10-28 Bbhc Co Ltd Método para la producción de célula madre pluripotente inducida a partir de célula madre mesenquimatosa y célula madre pluripotente inducida producida mediante el método
JP6452107B2 (ja) * 2014-09-05 2019-01-16 国立大学法人 東京大学 糖尿病性皮膚潰瘍治療のための多能性幹細胞
EP3245286A4 (fr) * 2015-01-17 2018-07-11 Zhejiang University Cellules modifiées induisant des réponses immunogènes réduites
EP3494979A4 (fr) * 2016-08-03 2020-03-04 Life Science Institute, Inc. Soulagement et traitement d'une lésion pulmonaire provoquée par une reperfusion ischémique à l'aide de cellules souches pluripotentes
CA3067963A1 (fr) * 2017-06-19 2018-12-27 National University Corporation Hokkaido University Agent de traitement de l' epidermolyse bulleuse
JP7255805B2 (ja) * 2017-06-20 2023-04-11 国立大学法人東海国立大学機構 多能性幹細胞による胎児発育不全に伴う脳障害の改善及び治療
EP3698802A4 (fr) * 2017-10-17 2021-05-26 Hiroshima University Cellules souches pluripotentes induisant une réparation ostéochondrale
CN110772535A (zh) * 2018-07-12 2020-02-11 南通大学 多系分化持续应激细胞在制备镇痛药物中的应用
CN115003795A (zh) 2019-11-14 2022-09-02 岛崎猛夫 细胞的重编程方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7202596A (en) * 1995-09-21 1997-04-09 Autoimmune, Inc. Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides
CA2422820A1 (fr) * 2000-09-19 2002-03-28 Novimmune S.A. Statines (inhibiteurs de la hmg-coa reductase) en tant que nouveau type d'agent immunomodulateur, immunosuppresseur et anti-inflammatoire
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020153991A (ja) * 2016-01-15 2020-09-24 国立大学法人富山大学 虚血性脳梗塞への多能性幹細胞の動員
JP2017151060A (ja) * 2016-02-26 2017-08-31 国立大学法人岐阜大学 急性心筋梗塞の予後マーカー及びその利用

Also Published As

Publication number Publication date
WO2012133948A1 (fr) 2012-10-04
CN103442724A (zh) 2013-12-11

Similar Documents

Publication Publication Date Title
JP7134317B2 (ja) 生体組織から単離できる多能性幹細胞
WO2012133948A1 (fr) Composition pour thérapie cellulaire par allogreffe, ladite composition contenant une cellule souche pluripotente positive pour ssea-3 pouvant être isolée de tissu corporel
US11261426B2 (en) Pluripotent stem cell that can be isolated from body tissue
WO2012133942A1 (fr) Cellule souche pluripotente pouvant être isolée de tissu adipeux ou de cordon ombilical de corps biologique
WO2011071085A1 (fr) Procédé pour produire des cellules induites pour être différenciées à partir de cellules souches pluripotentes
JP2023129719A (ja) ヒト多能性成人幹細胞

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20140805